There is growing evidence that cochlear implant recipients may benefit more from their devices if tonotopic mismatch is reduced. After providing an overview of recent research on tonotopic mismatch, this article explores how researchers and clinicians have been working to reduce tonotopic mismatch and improve hearing outcomes for MED-EL cochlear implant recipients.
A cochlear implant electrode serves not only as a crucial bridge between technology and nature that connects recipients to sound. The electrode array can significantly impact hearing outcomes. For instance, there is now growing consensus among researchers that stimulating more of the cochlea is associated with better speech perception and music appreciation. Here is the latest research you need to know to ensure each of your patients can benefit the most from their cochlear implant.
The active, transcutaneous BONEBRIDGE BCI 602 implant offers clear advantages over percutaneous BAHA (bone-anchored hearing aid) implants. Time and again, BAHAs are explanted and replaced with BONEBRIDGE. Leading ENT surgeons have reached an international consensus and established guidelines for the explantation of a BAHA followed by implantation of BCI 602.
We just revealed our latest innovations at CI2024 in Las Palmas de Gran Canaria, Spain. There we unveiled new tools to enable clinicians to provide follow-up fitting care remotely to MED-EL cochlear implant users without an appointment. We also offered a sneak peek into what’s coming soon for cochlear implantation and RONDO 3 users.
With endoscopic ear surgery, surgeons can get a wider field of view when implanting passive middle ear prostheses for ossicular reconstruction and stapes surgery. Learn what tips and tricks Prof. Dr. med. Lukas Anschütz has for using an endoscope while implanting tympanoplasty and stapes prostheses from MED-EL.
After receiving several hearing solutions that had no lasting success, a 13-year-old from Spain received bilateral active, transcutaneous BONEBRIDGE implants. In this case report, surgeons Dr. Estefanía Berrocal and Dr. Francisco Javier Aguilar explain the challenges associated with replacing an old implant and why the BONEBRIDGE implant is their "first choice for children."
.png)
